Feasibility Study of Adjuvant Chemotherapy with Carboplatin and Nab-Paclitaxel for Completely Resected NSCLC

PURPOSE: Adjuvant chemotherapy with cisplatin (CDDP) plus vinorelbine is the standard regimen for the treatment of non-small cell lung cancer (NSCLC). However, CDDP elicits severe toxic effects, including emesis, neurotoxicity, and renal damage; carboplatin (CBDCA) may be a feasible alternative for...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cancer Manag Res
Autores principales: Katsurada, Naoko, Tachihara, Motoko, Hatakeyama, Yukihisa, Koyama, Kiyoko, Yumura, Masako, Kiriu, Tatsunori, Dokuni, Ryota, Hazama, Daisuke, Tokunaga, Shuntaro, Tamura, Daisuke, Nakata, Kyosuke, Yamamoto, Masatsugu, Kamiryo, Hiroshi, Kobayashi, Kazuyuki, Tanaka, Yugo, Maniwa, Yoshimasa, Nishimura, Yoshihiro
Formato: Artigo
Lenguaje:Inglês
Publicado: Dove 2020
Materias:
Clinical Trial Report
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7007497/
https://ncbi.nlm.nih.gov/pubmed/32099473
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S239647
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares